Results
1 -
10 of
102Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review, Annals of Hematology Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers, Clinical Drug Investigation H??matoonkologisches Studienupdate ??? Targeted Therapies, Der Onkologe Anti-apoptotic Bcl-2, Cancer Therapeutic Targets MicroRNA Dysregulation to Identify Novel Therapeutic Targets, Viruses, Genes, and Cancer Treatment of Chronic Lymphocytic Leukemia and Related Disorders, Neoplastic Diseases of the Blood BCL2 Inhibitors: Insights into Resistance, Resistance of Targeted Therapies Excluding Antibodies for Lymphomas Sensitivity and Resistance to BH3 Mimetics in Cancer Therapy, Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways A History of the Chronic Leukemias, Neoplastic Diseases of the Blood Chronische lymphatische Leuk??mie beim alten und geriatrischen Patienten, Geriatrische Onkologie